Aries Agro reported a 17.87% increase in gross revenue for the financial year ended March 31, 2026, reaching ₹917.64 crore from ₹778.55 crore in the previous year. The micronutrient manufacturer sustained growth momentum despite geopolitical tensions and higher logistics costs, supported by robust demand in specialty nutrients.

Consolidated gross revenue surged to ₹956.88 crore, reflecting a compounded annual growth rate (CAGR) of 14.95% over five years. Consolidated EBITDA expanded to ₹8,885.79 lakh, while Profit Before Tax (PBT) rose significantly to ₹6,028.80 lakh, marking a 31.30% CAGR since FY22.

Subsidiary Performance and Capacity

The company’s domestic subsidiaries contributed significantly to the top-line expansion. Mirabelle Agro Manufacturing Private Limited grew 48.98%, while Aries Agro Equipments Private Limited recorded a 91.81% increase in revenue. Total capacity utilization stood at 72.55% against an installed capacity of 1,01,400 MT per annum, following the commissioning of a new facility in Sayakha, Gujarat.

Operational Efficiency and Strategic Shifts

Operational efficiencies improved markedly during the period. Inventory turnover days reduced to 71 days from 124 days in FY22, while trade receivables turnover dropped to 46 days from 100 days in FY22. This reduction indicates faster stock monetization and improved liquidity management.

Strategically, the company reduced its dependence on imported raw materials, which fell to 13% of total requirements in FY26 from 18% in FY25. This shift supports margin protection and reduces forex risk. New product launches included Aries Trillion, Aries Silica, and Agromin Max HD.

What the Numbers Show

The divergence between standalone revenue growth (17.87%) and consolidated revenue growth (approx. 18.9%) highlights the disproportionate contribution of subsidiaries. While the parent company faced cost pressures, the rapid scaling of Mirabelle Agro and Aries Agro Equipments acted as key accelerators, suggesting that the group’s diversification strategy into equipment and specialized manufacturing is yielding higher marginal returns than the core micronutrient business alone.

Outlook and Future Plans

For FY27, the company secured orders worth ₹1,084.40 crore through its annual booking programme, supporting an estimated gross revenue of approximately ₹1,010 crore. Management anticipates challenges from potential El Niño conditions and subdued farm-gate prices but plans to mitigate these through advance inventory planning and backward integration.

Aries Agro Limited reported a consolidated net profit of ₹14.8 crore for the first quarter ended June 30, 2026, marking a 49% year-on-year increase from ₹9.9 crore in Q1FY26. Revenue from operations rose 16% to ₹237.1 crore, supported by stronger net income from operations which grew to ₹185.9 crore from ₹159.8 crore in the prior year. The Board also declared dividend entitlements for FY26, with a record date set for September 22, 2026, and payment scheduled by October 23, 2026.

The results were approved by the Board on August 11, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory Auditors Kirti D. Shah & Associates conducted a limited review of the unaudited standalone and consolidated financial statements. The Company also announced the convening of its Annual General Meeting on September 29, 2026, to seek shareholder approval for director reappointments.

Financial Performance Highlights

Standalone net profit stood at ₹13.6 crore, up from ₹9.2 crore in the previous year. Total comprehensive income for the group was ₹14.1 crore, compared to ₹10.1 crore in Q1FY26. Earnings per share increased to ₹11.47 from ₹7.71 in the prior period.

Corporate Governance Updates

The Board approved the reappointment of Dr. Rahul Mirchandani as Managing Director for five years effective April 1, 2027, subject to shareholder approval via special resolution. Additionally, Mr. Nrupang Bhumitra Dholakia was reappointed as an Independent Director for a second five-year term starting March 15, 2027. Both appointments were recommended by the Nomination and Remuneration Committee.

What the Numbers Show

The 49% surge in net profit outpaced the 16% revenue growth, indicating improved operating leverage. While total expenses rose by 14.5%, they remained lower than the growth in net income from operations, allowing pre-tax profits to expand by 35%. This margin expansion suggests efficient cost management despite rising input costs, as consumption of materials increased by 32% but was offset by inventory adjustments and controlled employee benefits.